USPTO serial 88022705
OSNA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 11, 2022
- Examiner
- REEVES, APRIL ELIZABETH
- Law office
- TMO LAW OFFICE 124
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with OSNA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Virginia Wolk Marino
Virginia Wolk Marino CROWELL & MORINGP.O. BOX 10395CHICAGO, IL 60610UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or pharmaceutical purposes, namely, reagents for detecting metastasis of cancer; testing reagents and preparations for medical or veterinary purposes; pharmaceutical preparations for in vitro diagnosis; reagents for medical use, namely, reagents for genetic test; reagents for medical use, namely, reagents for amplification and detection of genes; reagents for medical use, namely, lymph node solubilizing reagents; reagents for medical use, namely, reagents for protein test; reagents for medical use, namely, reagents for cancer recurrence prediction test; reagents for medical use, namely, reagents for anticancer drug sensitivity prediction test; diluents for medical or veterinary purposes; diluents for medical or clinical diagnostic use; diluents for genetic test for medical or clinical diagnostic use; reference control materials for medical use; quality control standard solutions and quality control reagents for testing and calibrating medical apparatus and reagents | ACTIVE | — |
| 009 | Gene amplification or detection device for scientific or research use, namely, for detecting metastasis of cancer; laboratory apparatus and instruments, namely, for genetic testing for scientific and research purposes; measuring or testing machines and instruments for analyzing blood, body fluid, tissue or other biological samples not for medical purposes | ACTIVE | — |
| 010 | Diagnostic apparatus and instruments for medical purposes, namely, for testing DNA or RNA; diagnostic or measuring apparatus and instruments for medical purposes in the nature of genetic testing apparatus and instruments, namely, gene amplification detector, cancer metastasis analyzer, cell cycle analyzer, cancer recurrence prediction testing apparatus and instruments, anticancer drug sensitivity prediction testing apparatus and instruments, sample transfer apparatus, sample container transfer apparatus, and sample rack transfer apparatus; measuring apparatus and instruments for medical purposes for analyzing genes; pipettes for medical purposes; containers for samples for in vitro diagnosis; sampling bottles for medical purposes | ACTIVE | — |
| 042 | Medical or scientific research on cancer diagnosis; medical research; providing information relating to medical research; testing, examination or research of reagents and other medicines; testing, examination or research of medical apparatus and instruments and other machines; technological advice relating to medical apparatus and instruments, laboratory apparatus and instruments, measuring or testing machines and instruments, testing apparatus and instruments, computers and other machines; rental of gene amplification or detection device for scientific or research use; rental of laboratory apparatus and instruments; rental of measuring or testing machines and instruments for medical or scientific research; all of the foregoing for use with medical and scientific research in the field of cancer diagnosis | ACTIVE | — |
| 044 | Clinical genetic testing for detecting metastasis of cancer for diagnostic or treatment purposes; clinical testing of genes in lymph node for medical purposes; providing information relating clinical testing, namely, genetic testing; medical analysis and evaluation of clinical laboratory tests results for diagnosis of cancer metastasis or other diseases; providing medical information in the field of genetic testing; rental of medical apparatus and instruments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named OSNA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 4, 2023 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Mar 2, 2023 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Feb 3, 2023 | XXXX | POST REGISTRATION ACTION CORRECTION | — |
| Feb 3, 2023 | WDRL | OTQR WITHDRAWAL FROM PUBLICATION | — |
| Dec 20, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 20, 2022 | A7OK | AMENDMENT UNDER SECTION 7 - PROCESSED | — |
| Oct 28, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 11, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 11, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 8, 2022 | CHPN | POST PUBLICATION AMENDMENT – NOT ENTERED | — |
| Oct 4, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Sep 19, 2022 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Sep 8, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Aug 12, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Aug 5, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Aug 3, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 3, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Aug 3, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 3, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 1, 2022 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jul 28, 2022 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jul 28, 2022 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Feb 17, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 16, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Feb 16, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 9, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Feb 9, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 21, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 19, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 19, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 19, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 18, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 16, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 16, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 16, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 28, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 26, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 26, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 26, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 28, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 24, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 24, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 24, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 8, 2019 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Sep 25, 2019 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 10, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 16, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 16, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 12, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 10, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 10, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 10, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 6, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 8, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 8, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 8, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 9, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 9, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 8, 2019 | ALIE | ASSIGNED TO LIE | — |
| Apr 3, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 9, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 7, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 5, 2018 | NWAP | NEW APPLICATION ENTERED | — |